Access Resources
1761 - 1770 of 7540 Results
Title
Year
-
RESTRICTEDTitle: Neuroimaging Pearls from the MDS Congress Video Challenge. Part 2: Acquired DisordersJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: 3Start Page: 311End Page: 325Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13415Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13415Citation Count: 1
- An open-label prospective pilot trial of nucleus accumbens deep brain stimulation for children with autism spectrum disorder and severe, refractory self-injurious behavior: study protocol2022RESTRICTEDTitle: An open-label prospective pilot trial of nucleus accumbens deep brain stimulation for children with autism spectrum disorder and severe, refractory self-injurious behavior: study protocolJournal Name: Pilot and Feasibility StudiesPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40814-022-00988-3Best OA location URL: https://pilotfeasibilitystudies.biomedcentral.com/track/pdf/10.1186/s40814-022-00988-3Citation Count: 5
- Durability of the Clinical Benefit of Droxidopa for Neurogenic Orthostatic Hypotension During 12 Weeks of Open-Label Treatment2022RESTRICTEDTitle: Durability of the Clinical Benefit of Droxidopa for Neurogenic Orthostatic Hypotension During 12 Weeks of Open-Label TreatmentJournal Name: Neurology and TherapyPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 459End Page: 469Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40120-021-00317-5Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40120-021-00317-5.pdfCitation Count: 4
-
RESTRICTEDTitle: GBA and APOE Impact Cognitive Decline in Parkinson's Disease: A 10‐Year Population‐Based StudyJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 5Start Page: 1016End Page: 1027Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/mds.28932Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28932Citation Count: 43
- Transition and Sustainability of an Online Care Model for People With Parkinson's Disease in Response to the COVID-19 Pandemic2022RESTRICTEDTitle: Transition and Sustainability of an Online Care Model for People With Parkinson's Disease in Response to the COVID-19 PandemicJournal Name: Frontiers in Public HealthPublisher: Frontiers Media SAVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fpubh.2021.772805Best OA location URL: https://www.frontiersin.org/articles/10.3389/fpubh.2021.772805/pdfCitation Count: 4
- 4R-cembranoid protects neuronal cells from oxygen–glucose deprivation by modulating microglial cell activation2022RESTRICTEDTitle: 4R-cembranoid protects neuronal cells from oxygen–glucose deprivation by modulating microglial cell activationJournal Name: Brain Research BulletinPublisher: Elsevier BVVol: 179Issue #:Start Page: 74End Page: 82Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.brainresbull.2021.12.007Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8849140Citation Count: 5
- A double-hit in vivo model of GBA viral microRNA-mediated downregulation and human alpha-synuclein overexpression demonstrates nigrostriatal degeneration2022RESTRICTEDTitle: A double-hit in vivo model of GBA viral microRNA-mediated downregulation and human alpha-synuclein overexpression demonstrates nigrostriatal degenerationJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 163Issue #:Start Page: 105612End Page: 105612Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2022.105612Best OA location URL: https://doi.org/10.1016/j.nbd.2022.105612Citation Count: 1
-
RESTRICTEDTitle: Adjunctive Therapies in Parkinson Disease—Have We Made Meaningful Progress?Journal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 2Start Page: 119End Page: 119Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2021.4140Citation Count: 1
-
RESTRICTEDTitle: Association of Essential Tremor With Novel Risk LociJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 2Start Page: 185End Page: 185Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1001/jamaneurol.2021.4781Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2787239/jamaneurology_liao_2022_oi_210083_1644604359.06757.pdfCitation Count: 17
-
RESTRICTEDTitle: Australian Parkinson’s Genetics Study (APGS): pilot (n=1532)Journal Name: BMJ OpenPublisher: BMJVol: 12Issue #: 2Start Page: e052032End Page: e052032Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1136/bmjopen-2021-052032Best OA location URL: https://bmjopen.bmj.com/content/bmjopen/12/2/e052032.full.pdfCitation Count: 1